Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT

• Published in: Ophthalmic surgery, lasers & imaging Vol. 40; no. 1; pp. 65 - 67
• Main Authors: Kotoula, Maria G, Chatzoulis, Dimitrios Z, Karabatsas, Constantinos H, Tsiloulis, Aristoteles, Tsironi, Evangelia E
• Format: Journal Article
• Language: English
• Published: United States SLACK INCORPORATED 01.01.2009
• Subjects: Angiography; Edema; Exudates and Transudates; Exudation; Female; Fluorescein; Fluorescein Angiography; Fovea Centralis; Hemorrhage; Humans; Macular Edema - diagnosis; Macular Edema - drug therapy; Macular Edema - etiology; Medical imaging; Middle Aged; Ophthalmology; Photochemotherapy; Photodynamic therapy; Photosensitizing Agents - therapeutic use; Porphyrins - therapeutic use; Radiation; Retina; Retinal Diseases - complications; Retinal Diseases - diagnosis; Retinal Diseases - drug therapy; Retinal Vessels - drug effects; Retinal Vessels - pathology; Telangiectasis - complications; Telangiectasis - diagnosis; Telangiectasis - drug therapy; Visual Acuity
• ISSN: 1542-8877; 2325-8160; 2325-8179
• DOI: 10.3928/15428877-20090101-10

A 57-year-old woman was treated by photodynamic therapy for macular edema due to idiopathic juxtafoveal telangiectasis (presumed type 1A) without subretinal neovascularization. Initial visual acuity of the treated eye was 20/200 and it improved to 20/40 by 3 months after the photodynamic therapy session. Visual acuity remained stable 32 months after the treatment. Color photographs and fundus fluorescein angiography before and after photodynamic therapy revealed regression of hemorrhages, exudates, and fluorescein leakage. Photodynamic therapy has long-term benefits for the patient with idiopathic juxtafoveal telangiectasis, presumed type 1A, because it can improve visual acuity and macular edema.